Mostrando 551,361 - 551,380 Resultados de 551,884 Para Buscar '"infection"', tiempo de consulta: 3.62s Limitar resultados
  1. 551361
    “…Higher levels of accelerometer-measured physical activity were associated with lower risks of hospitalization for 9 conditions: gallbladder disease (HR per 1 SD, 0.74; 95% CI, 0.69-0.79), urinary tract infections (HR per 1 SD, 0.76; 95% CI, 0.69-0.84), diabetes (HR per 1 SD, 0.79; 95% CI, 0.74-0.84), venous thromboembolism (HR per 1 SD, 0.82; 95% CI, 0.75-0.90), pneumonia (HR per 1 SD, 0.83; 95% CI, 0.77-0.89), ischemic stroke (HR per 1 SD, 0.85; 95% CI, 0.76-0.95), iron deficiency anemia (HR per 1 SD, 0.91; 95% CI, 0.84-0.98), diverticular disease (HR per 1 SD, 0.94; 95% CI, 0.90-0.99), and colon polyps (HR per 1 SD, 0.96; 95% CI, 0.94-0.99). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 551362
    “…L'administration d'une dose additionnelle de vaccin (3e ou 4e dose) comparativement à des patients vaccinés ne bénéficiant pas de cette dose additionnelle, non récemment infectés, permettait de réduire de 50 % le risque d'hospitalisation sur une durée de 4 mois. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 551363
  4. 551364
    “…Our peers are able to offer both POC antibody testing and, for those who have been exposed to HCV (currently infected, treated or cleared), RNA testing by dried blood spot. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 551365
  6. 551366
  7. 551367
    “…The hazard for interruption was higher for low baseline CD4 + T-cell counts, higher baseline HIV-RNA, non-Italian nationality, older age, PWID and possible co-infections with hepatitis viruses. The risk ratio was higher for past history of cART use compared to persons who were cART naive, use of regimens containing 3 drugs compared to regimens containing 2 drugs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 551368
    “…Sporozoite rates and entomological inoculation rates did not differ significantly between study arms (sporozoite rate: 0.9% vs 1.1%, p = 0. 0.746, EIR: 0.008 vs 0.006 infective bites per person per night, p = 0.589). Cone bioassay mortality with both VECTRON™ T500 and Fludora® Fusion was 100% for 24 months post-IRS application on both cement and mud treated house walls with both susceptible and pyrethroid-resistant strains of An. gambiae s.l. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 551369
  10. 551370
    “…Phase 1 (February–June 2018) utilised standard HTS services: counsellor-led height/weight/blood pressure measurements, HIV rapid testing, and symptoms screening for sexually transmitted infections/Tuberculosis. Phase 2 (June 2018–March 2019) further integrated counsellor-led obesity screening (body mass index/abdominal circumference measurements), rapid cholesterol/glucose testing; and nurse-led Chlamydia and human papilloma virus (HPV)/cervical cancer screening. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 551371
    “…BACKGROUND: Corynebacterium striatum was confirmed to be an important opportunistic pathogen, which could lead to multiple-site infections and presented high prevalence of multidrug resistance, particularly to quinolone antibiotics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 551372
    “…Sixteen percent (16/98) of the patients each infected at least one mosquito on day 7, and of these, 10.0% (2/20) and 17.9% (14/78) had reduced and normal CYP2D6 enzyme activity, respectively (x(2) = 0.736, p = 0.513). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 551373
    por Giuliani, Francesca, Oros, Daniel, Gunier, Robert B., Deantoni, Sonia, Rauch, Stephen, Casale, Roberto, Nieto, Ricardo, Bertino, Enrico, Rego, Albertina, Menis, Camilla, Gravett, Michael G., Candiani, Massimo, Deruelle, Philippe, García-May, Perla K., Mhatre, Mohak, Usman, Mustapha Ado, Abd-Elsalam, Sherief, Etuk, Saturday, Napolitano, Raffaele, Liu, Becky, Prefumo, Federico, Savasi, Valeria, Do Vale, Marynéa Silva, Baafi, Eric, Ariff, Shabina, Maiz, Nerea, Aminu, Muhammad Baffah, Cardona-Perez, Jorge Arturo, Craik, Rachel, Tavchioska, Gabriela, Bako, Babagana, Benski, Caroline, Hassan-Hanga, Fatimah, Savorani, Mónica, Sentilhes, Loïc, Carola Capelli, Maria, Takahashi, Ken, Vecchiarelli, Carmen, Ikenoue, Satoru, Thiruvengadam, Ramachandran, Soto Conti, Constanza P., Cetin, Irene, Nachinab, Vincent Bizor, Ernawati, Ernawati, Duro, Eduardo A., Kholin, Alexey, Teji, Jagjit Singh, Easter, Sarah Rae, Salomon, Laurent J., Ayede, Adejumoke Idowu, Cerbo, Rosa Maria, Agyeman-Duah, Josephine, Roggero, Paola, Eskenazi, Brenda, Langer, Ana, Bhutta, Zulfiqar A., Kennedy, Stephen H., Papageorghiou, Aris T., Villar, Jose
    Publicado 2022
    “…STUDY DESIGN: In this cohort study that took place from March 2020 to March 2021, involving 43 institutions in 18 countries, 2 unmatched, consecutive, unexposed women were concomitantly enrolled immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care to minimize bias. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 551374
  15. 551375
    Publicado 2023
    “…Neonatal disorders, followed by ischaemic heart disease, stroke, diarrhoeal diseases, and lower respiratory infections were the leading causes of all-age premature mortality in 2019. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 551376
  17. 551377
    “…In the safety population, 113 (89%) of 127 patients in the ravulizumab plus BSC group and 56 (84%) of 67 in the BSC group had a treatment-emergent adverse event. Of these events, infections and infestations (73 [57%] vs 24 [36%] patients) and vascular disorders (39 [31%] vs 12 [18%]) were observed more frequently in the ravulizumab plus BSC group than in the BSC group. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 551378
  19. 551379
  20. 551380
Herramientas de búsqueda: RSS